Brookline Capital Acquisition Corp (BCAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAC | CKPT | SKYE | ||
| Company | Brookline Capital Acquisition Corp | Checkpoint Therapeutics Inc | Skye Bioscience Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.07 | 3.81 | 5.55 | ||
| High | 27.74 | 3.93 | 5.63 | ||
| Low | 9.94 | 3.41 | 4.32 | ||
| Last | 22.71 | 3.43 | 4.95 | ||
| Change | +12.63 | -0.35 | -0.56 | ||
| % Change | +125.30% | -9.26% | -10.16% | ||
| Volume | 586,400 | 1,021,600 | 419,700 | ||
| 20-Day Average Volume | 69,480 | 1,211,150 | 195,870 | ||
| Previous Close | 10.08 | 3.78 | 5.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.81 | 3.47 | 5.25 | ||
| 20-Day Raw Stochastic | 72.42% | 45.45% | 38.41% | ||
| 20-Day Relative Strength | 93.64% | 57.05% | 48.60% | ||
| Weighted Alpha | +26.80 | +127.86 | -13.94 | ||
| Today's Opinion | 100% Buy | 88% Buy | 56% Sell | ||
| Previous Opinion | 40% Buy | 100% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +130.09% since 07/22/22 | +1.78% since 11/08/24 | -13.31% since 11/08/24 | ||
| Low | 9.68 on 07/25/22 | 3.09 on 11/11/24 | 4.32 on 11/15/24 | ||
| High | 27.74 on 07/29/22 | 3.95 on 11/14/24 | 5.90 on 11/11/24 | ||
| 1-Month | |||||
| %Chg | +123.52% since 06/29/22 | +29.92% since 10/15/24 | +17.86% since 10/15/24 | ||
| Low | 9.50 on 07/22/22 | 2.65 on 10/16/24 | 4.01 on 10/18/24 | ||
| High | 27.74 on 07/29/22 | 3.97 on 10/30/24 | 5.96 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | +124.52% since 04/29/22 | +53.81% since 08/15/24 | -1.79% since 08/15/24 | ||
| Low | 9.50 on 07/22/22 | 2.06 on 09/10/24 | 2.95 on 09/20/24 | ||
| High | 27.74 on 07/29/22 | 3.97 on 10/30/24 | 7.47 on 08/27/24 | ||
| 6-Month | |||||
| %Chg | +127.10% since 01/28/22 | +110.43% since 05/15/24 | -60.96% since 05/15/24 | ||
| Low | 9.50 on 07/22/22 | 1.60 on 05/16/24 | 2.95 on 09/20/24 | ||
| High | 27.74 on 07/29/22 | 3.97 on 10/30/24 | 13.44 on 05/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 153,204 | 154,412 | 150,173 | ||
| Shares Outstanding, K | 6,746 | 45,018 | 30,338 | ||
| Annual Sales | 0 | 100,000 | 0 | ||
| Annual Net Income | -480,000 | -51,850,000 | -37,640,000 | ||
| Last Quarter Sales | 0 | 40,000 | 0 | ||
| Last Quarter Net Income | -2,457,658 | -6,670,000 | -3,900,000 | ||
| 60-Month Beta | -0.03 | 1.23 | 1.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/23/22 | -0.23 on 11/12/24 | -0.22 on 11/07/24 | ||
| Latest Earnings Date | 07/04/22 | 11/11/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||